Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02683850 · ClinicalTrials.gov registry record · Early Phase 1
Influence of an Omega-3 SPM Supplement on Quality of Life
A Early Phase 1 study, sponsored by National University of Natural Medicine.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 44
- Enrollment target
NCT02683850 is a Early Phase 1 study that has completed, run by National University of Natural Medicine. The registered enrollment target is 44 participants.
The verdict
NCT02683850, a Early Phase 1 study, has completed, sponsored by National University of Natural Medicine.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 44 participants
- Enrollment target
Study Summary
This prospective, non-randomized, open-label study will assess if taking an Omega-3 SPM™ soft gel supplement for four weeks will increase the quality of life in adults with chronic pain.
Interventions
- DIETARY_SUPPLEMENT Omega-3 SPM™ softgel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2016-01 |
| Est. Completion | 2016-07 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02683850
The ClinicalTrials.gov registry entry for NCT02683850 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National University of Natural Medicine, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Omega-3 SPM™ softgel is the first listed.
NCT02683850 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02683850 about?
NCT02683850 is a clinical study titled "Influence of an Omega-3 SPM Supplement on Quality of Life". This prospective, non-randomized, open-label study will assess if taking an Omega-3 SPM™ soft gel supplement for four weeks will increase the quality of life in adults with chronic pain.
What is the current status of trial NCT02683850?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 44 participants. The study started on 2016-01. Estimated completion is 2016-07.
What interventions are being tested in trial NCT02683850?
The interventions under investigation include: Omega-3 SPM™ softgel (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02683850?
This trial is sponsored by National University of Natural Medicine, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.